Albert Lowe
Stock Analyst at Craig-Hallum
(1.07)
# 3,554
Out of 4,734 analysts
5
Total ratings
40%
Success rate
-7.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Albert Lowe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Initiates: Buy | $11 | $3.67 | +199.73% | 1 | Oct 9, 2024 | |
| CRDF Cardiff Oncology | Initiates: Buy | $8 | $3.52 | +127.27% | 1 | Sep 6, 2024 | |
| LCTX Lineage Cell Therapeutics | Initiates: Buy | $4 | $0.59 | +579.81% | 1 | Aug 20, 2024 | |
| SKYE Skye Bioscience | Initiates: Buy | $18 | $2.70 | +566.67% | 1 | Jul 9, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $6 | $1.35 | +344.44% | 1 | May 13, 2024 |
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $3.67
Upside: +199.73%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $3.52
Upside: +127.27%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $0.59
Upside: +579.81%
Skye Bioscience
Jul 9, 2024
Initiates: Buy
Price Target: $18
Current: $2.70
Upside: +566.67%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.35
Upside: +344.44%